Live from the NIH registry
Studies recruiting near Poughkeepsie right now
Top 25 of 78 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1050 — Monroe, New York (28.7 mi)
· Sponsor: Immunovant Sciences GmbH
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: NRG Oncology
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Westchester Putnam Gastroenterology — Carmel, New York (22.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — New Windsor, New York (16.0 mi)
· Sponsor: GlaxoSmithKline
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Metastatic Cancer, Neoplasm, Prostate
Phase 2
Interventional 192 participants sought
VA Hudson Valley Health Care System — Wappingers Falls, New York (6.8 mi)
· Sponsor: Sun Pharmaceutical Industries Limited
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer Disease, Agitation
Phase 3
Interventional 650 participants sought
Local Institution - 1656 — New Windsor, New York (16.0 mi)
· Sponsor: Bristol-Myers Squibb
Examining the Most Effective Method to Reduce Running Ground Contact Time
Healthy Runners
N/A
Interventional 30 participants sought
Keller Army Community Hospital — West Point, New York (21.0 mi)
· Sponsor: Keller Army Community Hospital
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk077 — Rhinebeck, New York (16.0 mi)
· Sponsor: Mirati Therapeutics Inc.
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: DalCor Pharmaceuticals
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — New Windsor, New York (16.0 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
Collection of Samples USOPTIVAL Study
Colorectal Cancer (CRC), Advanced Adenomas (AA)
N/A
Observational 1,300 participants sought
Mid Hudson Medical Research — New Windsor, New York (16.0 mi)
· Sponsor: Universal Diagnostics
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Mid Hudson Medical Research - New Windsor- Site Number : 8400004 — New Windsor, New York (16.0 mi)
· Sponsor: Sanofi
Myriad™ Augmented Soft Tissue Reconstruction Registry
Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection
N/A
Observational 800 participants sought
Nuvance Health Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: Aroa Biosurgery Limited
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Hudson Valley Urology, PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Hematologic Disorder, Bleeding Disorder
N/A
Observational 3,000 participants sought
Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center — Hyde Park, New York (6.2 mi)
· Sponsor: American Thrombosis and Hemostasis Network
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Melanoma, Glioma
Phase 1
Interventional 124 participants sought
Optum Medical Care, PC — Brewster, New York (25.9 mi)
· Sponsor: Pfizer
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: Alnylam Pharmaceuticals
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Cardiovascular Disease
Phase 3
Interventional 11,000 participants sought
Hudson Valley Cardiovascular Physicians PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Amgen
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Nuvance Health — Poughkeepsie, New York (0.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 74 participants sought
Research Site — Newburgh, New York (14.0 mi)
· Sponsor: Maze Therapeutics
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Premier Medical Group of the Hudson Valley, P. C. — Poughkeepsie, New York (0.4 mi)
· Sponsor: Pacific Edge Limited
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Acne Vulgaris
Phase 4
Interventional 100 participants sought
Vitality Clinical Trials, LLC — Woodbury, New York (24.8 mi)
· Sponsor: Bausch Health Americas, Inc.
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: AtriCure, Inc.